| Literature DB >> 34530507 |
Huan Yang1, Chi Ma1, Yang Zi1, Min Zhang1, Yingchun Liu2, Kaifeng Wu2, Feng Gao1,3.
Abstract
OBJECTIVE: The experiment was conducted to evaluate the effects of maternal undernutrition during late pregnancy on the expressions of genes involved in growth and development in ovine fetal perirenal brown adipose tissue (BAT).Entities:
Keywords: Brown Preadipocytes; Growth and Development; Maternal Undernutrition; Ovine Perirenal Adipose Tissue
Year: 2021 PMID: 34530507 PMCID: PMC9271387 DOI: 10.5713/ab.21.0199
Source DB: PubMed Journal: Anim Biosci ISSN: 2765-0189
Planes of maternal nutrition in three groups of ewes during late pregnancy
| Treatments | RG2[ | RG1[ | CG[ |
|---|---|---|---|
| Mean daily hay intake (g/d)[ | 440 | 843 | 1,689 |
| Mean daily crude protein intake (g/d) | 44 | 85 | 170 |
| Daily metabolizable energy intake (MJ ME/kg W0.75/d)[ | 0.18 | 0.33 | 0.67 |
ME, metabolisable energy.
RG2, restricted group 2; RG1, restricted group 1; CG, control group.
Mean daily hay intake and crude protein intake are represented on a natural basis.
Daily metabolizable energy intake is represented on a dry matter basis.
Composition of hay and refusals during the restriction period
| Items | Grass hay | Refusals |
|---|---|---|
| ME (MJ/kg) | 8.90 | - |
| DM (%) | 88.42 | 91.99 |
| CP (%) | 10.09 | 9.27 |
| EE (%) | 4.34 | 2.72 |
| NDF (%) | 71.98 | 71.19 |
| ADF (%) | 35.82 | 36.60 |
| Ash (%) | 4.67 | 4.39 |
| Ca (%) | 0.57 | 0.68 |
| P (%) | 0.09 | 0.08 |
ME, metabolisable energy; DM, dry matter; CP, crude protein; EE, ether extract; NDF, neutraldetergent fiber; ADF, acid detergent fiber; Ca, calcium; P, phosphorus.
The sequence of primers used in PCR analysis
| Gene | Primer sequence (5′-3′) | Amplicon length (bp) | Amplification efficiency (%) |
|---|---|---|---|
|
| 5′-AGCAACCTGGATTGCCTCTC-3′ | 78 | 99.7 |
| 5′-CTGGAGTTGCAGGCTGAGAA-3′ | |||
|
| 5′-CAACAGAAGGCTTGACGG-3′ | 200 | 100.8 |
| 5′-CTGGCGAGGACAGAACC-3′ | |||
|
| 5′-TGGCAGAATCCCACTCAC-3′ | 335 | 95.3 |
| 5′-AGACTACCACCTGGCTCAA-3′ | |||
|
| 5′-TGCCGATTCCAGAAGTGCCTTG-3′ | 118 | 102.1 |
| 5′-GTTGGTCGATGTCGCTGGAGATC-3′ | |||
|
| 5′-ACAGCAACGAATACCGGGTG-3′ | 97 | 106.2 |
| 5′-TTCTGTTGCGTCTCCACGTT-3′ | |||
|
| 5′-CCGCCTCTGCTACCTCCTACG-3′ | 136 | 96.8 |
| 5′-CTGTGGTGCTCTGGCTACTGTTG-3′ | |||
|
| 5′-AGCTCCACGACTCCAGACAACTAG-3′ | 287 | 107.3 |
| 5′-TCTCAGGTAGCACAGGTCGGAATC-3′ | |||
|
| 5′-GCTGCTGCGGCGGAATGTAC-3′ | 102 | 96.8 |
| 5′-GTTGGTCGATGTCGCTGGAGATC-3′ | |||
|
| 5′-GAAGGCTGGACCACTGGAGGAG-3′ | 148 | 98.9 |
| 5′-GGATGTGCCGAGGAGGAGTCTG-3′ | |||
|
| 5′-ACCAGGCTACCAGGCGTTCTAC-3′ | 81 | 95.3 |
| 5′-ATGGCGTGGTTGGTTGAGTTGAG-3′ | |||
|
| 5′-AGGCTATGCCGCCTACTACT-3′ | 101 | 104.2 |
| 5′-TGAAGTGTACCAGCGTCTGC-3′ | |||
|
| 5′-ACTACTACGCCAAGGAGGTCACC-3′ | 140 | 98.3 |
| 5′-CACAGGTTCAGGCACTGCTTCC-3′ | |||
|
| 5′-ACCATGAGGACATTCACACGTACC-3′ | 124 | 99.2 |
| 5′-ACTAACCAGTCCACGAGGATAGCC-3′ | |||
|
| 5′-GGAAATGTACCCTCCAGAAATCG-3′ | 232 | 105.5 |
| 5′-CATATCGTAGTCCAGCATAGTTAGTT-3′ | |||
|
| 5′-ACATGGAGCTGGTCCTGGTG-3′ | 188 | 93.6 |
| 5′-GGAGGGTGGGTTGGAAATGA-3′ | |||
|
| 5′-GAGAAGCCAGTGTGGCAGTC-3′ | 157 | 98.3 |
| 5′-CGACGCTCTGGATGACGATG-3′ | |||
|
| 5′-GTCAAGTGGTAGCCATGAAGAA-3′ | 218 | 103.7 |
| 5′-GAACTGACCAGGAGGGATAGAA-3′ | |||
|
| 5′-ACAAGTTGACGGGAGAAGTG-3′ | 235 | 97.9 |
| 5′-AGAGGAATGCCAGTGAGTGC-3′ | |||
|
| 5′-CAGTGGCTGAGATTGGTGTCG-3′ | 148 | 102.5 |
| 5′-ACCTCCCGAACGGTGCTGAT-3′ | |||
|
| 5′-AGGTGCTGAAGGTGCAGAAACGG-3′ | 283 | 98.2 |
| 5′-CGAAGGTCCTGGCAGGTCACATA-3′ | |||
|
| 5′-GGGTGCTAACAGGAAGAAATGGA-3′ | 134 | 99.4 |
| 5′-GCAAATGGCTCTAAATGAGGGTAAAT-3′ | |||
|
| 5′-CTTCACATCCACCAACCCTCCAC-3′ | 199 | 102.3 |
| 5′-GAACAGTCTTGCGGCAGTAAACG-3′ | |||
|
| 5′-TCTTCCAGCCGTCCTTCCT-3′ | 144 | 96.7 |
| 5′-TGCCAGGGTACATGGTGGT-3′ |
Myf5, myogenic factor 5; UCP1, uncoupling protein 1; PPARγ, peroxisome proliferator-activated receptor-γ; C/EBPα, CCAAT/enhancer-binding protein-α; PRDM16, positive regulatory domain-containing protein 16; PGC-1α, peroxisome proliferator-activated receptor co-activator-1α; KLF4, Krüppel-like factor 4; EBF2, early B-cell factor 2; BMP4, bone morphogenetic protein 4; TGFβ, transforming growth factor type-β; CDK1, cyclin-dependent kinase 1; E2F1, E2F transcription factor 1.
Effects of maternal undernutrition during late pregnancy on fetal body weight, the fetal perirenal fat weight
| Items | CG[ | RG1[ | RG2[ | SEM | p-value |
|---|---|---|---|---|---|
| BW (g) | 3,978[ | 3,573[ | 3,111[ | 111.00 | 0.0069 |
| Perirenal fat weight (g) | 11.57[ | 10.17[ | 6.44[ | 1.340 | 0.0077 |
| Perirenal fat index of BW (%) | 0.29 | 0.28 | 0.20 | 0.0003 | 0.0613 |
| Perirenal fat growth rate (g/d) | 0.21[ | 0.18[ | 0.11[ | 0.0278 | 0.0074 |
SEM, standard error of the mean; BW, body weight.
CG: control group, ad libitum, 0.67 MJ ME/kg BW0.75/d; RG1: restricted group1, 0.33 MJ ME/kg BW0.75/d; RG2: restricted group2, 0.18 MJ ME/kg BW0.75/d.
Means without a common superscript differ between CG, RG1, and RG2 (p<0.05).
Figure 1Effect of maternal undernutrition during late pregnancy on the histology and UCP1 expression of perinatal adipose tissue in ovine fetuses. (a) H&E staining of sections of fetal perinatal adipose tissues (A–C the large and small arrows indicate brown adipose tissue and white adipose tissue, respectively [bar = 50 μm]) and immunohistochemical staining of UCP1 expression in fetal perirenal BAT (D–F, bar = 50 μm). (b) relative mRNA level of UCP1. (c) quantitative data in immunohistochemical analysis of UCP1. (d) western blot of UCP1. UCP1 protein expression of all samples was expressed as fold changes, calculated relative to the CG group. a,b Bars with different superscript differ (p<0.05). UCP1, uncoupling protein 1; H&E, hematoxylin and eosin.
Figure 2Effect of maternal undernutrition during late pregnancy on expression of Myf5 in fetal peripheral brown adipose tissue. (a) Relative mRNA level of Myf5. (b) Western blot of Myf5. Myf5 protein expression of all samples was expressed as fold changes, calculated relative to the CG group. a,b Bars without a different superscript differ (p<0.05). Myf5, myogenic factor 5.
Figure 3Effect of maternal undernutrition during late pregnancy on relative mRNA levels of cell cycle regulatory factors in fetal peripheral brown adipose tissue. a,b Bars with different superscript differ (p<0.05).
Figure 4Effect of maternal undernutrition during late pregnancy on expression of PPARγ and C/EBPα in fetal perirenal adipose tissue. (a) relative mRNA level of PPARγ and C/EBPα. (b) Western blot of PPARγ. (c) Western blot of C/EBPα. PPARγ and C/EBPα protein expression of all samples were expressed as fold changes, calculated relative to the CG group. (d) quantitative data in immunohistochemical analysis of PPARγ. (e) quantitative data in immunohistochemical analysis of C/EBPα. (f) immunohistochemical staining of PPARγ and C/EBPα expression in fetal perirenal BAT (bar = 50 μm), the arrows indicate the location of the nucleus expressing PPARγ and CEBPα, to respectively. PPARγ, peroxisome proliferator-activated receptor-γ; C/EBPα, CCAAT/enhancer-binding protein-α; BAT, brown adipose tissue. a,b Bars with a different superscript differ (p<0.05).
Effect of maternal undernutrition during late pregnancy on expression of others regulatory factors in fetal perirenal brown adipose tissue
| Items | CG[ | RG1[ | RG2[ | SEM | p-value |
|---|---|---|---|---|---|
| Adipose precursor cell development factor | |||||
| EBF2 | 1.00 | 0.91 | 0.81 | 0.214 | 0.6757 |
| BMP7 | 1.00[ | 0.70[ | 0.56[ | 0.097 | 0.0330 |
| BMP4 | 1.00[ | 0.89[ | 0.61[ | 0.104 | 0.0083 |
| Differentiation promoting transcription factors | |||||
| PRDM16 | 1.00 | 0.85 | 0.89 | 0.154 | 0.6146 |
| PGC-1α | 1.00[ | 0.73[ | 0.56[ | 0.073 | 0.0104 |
| KLF4 | 1.00 | 1.03 | 1.34 | 0.264 | 0.4274 |
| Differentiation inhibiting transcription factors | |||||
| GATA2 | 1.00 | 1.08 | 0.89 | 0.161 | 0.0897 |
| TGFβ | 1.00 | 1.31 | 1.06 | 0.111 | 0.1223 |
SEM, standard error of the mean; EBF2, early B-cell factor 2; BMP7/4, bone morphogenetic protein 7/4; PRDM16, positive regulatory domain-containing protein; PGC-1α, peroxisome proliferator-activated receptor co-activator-1α; KLF4, Krüppel-like factor 4; GATA2, GATA binding protein 2; TGFβ, transforming growth factor type-β.
CG: control group, ad libitum, 0.67 MJ ME/kg BW0.75/d; RG1: restricted group 1, 0.33 MJ ME/kg BW0.75/d; RG2: restricted group 2, 0.18 MJ ME/kg BW0.75/d.
Means without a common superscript differ among CG, RG1, and RG2 (p<0.05).